Our Research & Development
Ironwood invests to bring important medicines to patients through the
development of innovative products in areas of high unmet need.
Our U.S. pipeline:
Status of Selected Key Development Programs as of November 6, 2018.
Represents ongoing phase of development; does not correspond to initiation or completion of a particular phase.
Status of Selected Key Development Programs as of November 6, 2018.
Represents ongoing phase of development; does not correspond to initiation or completion of a particular phase.
* Click here for LINZESS full US Prescribing Information including BOXED WARNING »
† Find out more about our pipeline of sGC stimulators »
† Find out more about our pipeline of sGC stimulators »
For information about our clinical trials. please go to www.clinicaltrials.gov.
